Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jul 18:14:1443878.
doi: 10.3389/fonc.2024.1443878. eCollection 2024.

Editorial: Organ-sparing surgery for genitourinary cancers

Gongwei Long  1 , Xingyuan Xiao  2 , Haoran Liu  3   4 , Yucong Zhang  5 , Chunguang Yang  6
Affiliations
Editorial

Editorial: Organ-sparing surgery for genitourinary cancers

Gongwei Long et al. Front Oncol. .
No abstract available

Keywords: bladder cancer; genitourinary cancers; organ-sparing surgery; radical cystectomy; renal tumor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Organ-sparing surgery for genitourinary cancers

References

    1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. (2024) 74:12–49. doi: 10.3322/caac.21820 - DOI - PubMed
    1. Djaladat H, Katebian B, Bazargani ST, Miranda G, Cai J, Schuckman AK, et al. . 90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study. World J Urol. (2017) 35:907–11. doi: 10.1007/s00345-016-1950-z - DOI - PubMed
    1. Giacalone NJ, Shipley WU, Clayman RH, Niemierko A, Drumm M, Heney NM, et al. . Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer: an updated analysis of the massachusetts general hospital experience. Eur Urol. (2017) 71:952–60. doi: 10.1016/j.eururo.2016.12.020 - DOI - PubMed
    1. Mazza P, Moran GW, Li G, Robins DJ, Matulay JT, Herr HW, et al. . Conservative management following complete clinical response to neoadjuvant chemotherapy of muscle invasive bladder cancer: contemporary outcomes of a multi-institutional cohort study. J Urol. (2018) 200:1005–13. doi: 10.1016/j.juro.2018.05.078 - DOI - PMC - PubMed
    1. Shi H, Zhang W, Bi X, Wang D, Xiao Z, Guan Y, et al. . Neoadjuvant chemotherapy-guided bladder-sparing treatment for muscle-invasive bladder cancer: results of a pilot phase II study. Cancer Res Treat. (2021) 53:1156–65. doi: 10.4143/crt.2020.1356 - DOI - PMC - PubMed

Publication types

LinkOut - more resources